XML 30 R19.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segment Reporting
9 Months Ended
Sep. 30, 2018
Segment Reporting [Abstract]  
Segment Reporting

14. Segment Reporting

Operating segments are components of an enterprise for which separate financial information is available and is evaluated regularly by the Company’s chief operating decision-maker in deciding how to allocate resources and in assessing performance. The Company has one reportable segment which designs, develops, manufactures and markets medical devices for non-surgical approaches to treating type 2 diabetes and obesity.

Geographic Reporting

All the Company’s revenue is attributable to customers outside the U.S. The Company is dependent on favorable economic and regulatory environments for its products. Products were sold to customers located in Europe and the Middle East and sales were attributed to a country or region based on the location of the customer to whom the products were sold.

At September 30, 2018, long-lived assets, comprised of property and equipment, of approximately $0.1 million are all held in the U.S.

Product sales by geographic location for the three and nine months ended September 30, 2018 and 2017 are listed in the table below (in thousands):

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2018

 

 

2017

 

 

2018

 

 

2017

 

Europe

 

$

 

 

$

23

 

 

$

 

 

$

155

 

Middle East

 

 

 

 

 

-

 

 

 

 

 

 

18

 

Total

 

$

 

 

$

23

 

 

$

 

 

$

173

 

 

The Company did not have revenue for the three and nine months ended September 30, 2018.

Germany was a significant component of revenue in Europe for the three and nine months ended September 30, 2017.

Major Customers

The Company did not recognize any revenue for the three and nine months ended September 30, 2018.

For the three months ended September 30, 2017, the Company recognized as revenue a reversal of prior rebate accruals of approximately $27 thousand originally granted to health care providers which was deemed to no longer be required, in addition the Company deferred a previously recognized sale.  

For the nine months ended September 30, 2017, two customers accounted for 21% and 15% of the Company’s revenue.